{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:52:54Z","timestamp":1740135174896,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T00:00:00Z","timestamp":1532131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3242-2","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T04:55:39Z","timestamp":1532148939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5831-7639","authenticated-orcid":false,"given":"Kristel","family":"Kivimets","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anneli","family":"Uusk\u00fcla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey V.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,21]]},"reference":[{"issue":"21","key":"3242_CR1","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.4254\/wjh.v7.i21.2323","volume":"7","author":"R Zampino","year":"2015","unstructured":"Zampino R, Coppola N, Sagnelli C, Di Caprio G, Sagnelli E. Hepatitis C virus infection and prisoners: epidemiology, outcome and treatment. World J Hepatol. 2015;7(21):2323\u201330.","journal-title":"World J Hepatol"},{"key":"3242_CR2","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","volume":"388","author":"K Dolan","year":"2016","unstructured":"Dolan K, Wirtz AL, Moazen B, Ndeff o-mbah M, Galvani A, Kinner SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388:1089\u2013102.","journal-title":"Lancet"},{"key":"3242_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/jurban\/jth085","volume":"81","author":"L Solomon","year":"2004","unstructured":"Solomon L, Flynn C, Muck K, Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health. 2004;81:25.","journal-title":"J Urban Health"},{"issue":"7","key":"3242_CR4","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2105\/AJPH.94.7.1218","volume":"94","author":"GE Macalino","year":"2004","unstructured":"Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;94(7):1218\u201323.","journal-title":"Am J Public Health"},{"issue":"2","key":"3242_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1086\/430913","volume":"41","author":"RK Fox","year":"2005","unstructured":"Fox RK, Currie SL, Evans J, Wright TL, Tobler L, Phelps T, et al. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis. 2005;41(2):177\u201386.","journal-title":"Clin Infect Dis"},{"key":"3242_CR6","volume-title":"Prisons and drugs in Europe: the problem and responses","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2012","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Prisons and drugs in Europe: the problem and responses. Luxembourg: Publications Office of the European Union; 2012. Accessed 1 Sept 2015"},{"issue":"4","key":"3242_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1136\/jech.2006.051599","volume":"62","author":"MF Vescio","year":"2008","unstructured":"Vescio MF, Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, et al. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health. 2008;62(4):305\u201313.","journal-title":"J Epidemiol Community Health"},{"key":"3242_CR8","volume-title":"UNAIDS report on the AIDS global epidemic 2013 (appendix)","author":"UNAIDS","year":"2013","unstructured":"UNAIDS. UNAIDS report on the AIDS global epidemic 2013 (appendix). Geneva: Joint United Nations Programme on HIV\/AIDS; 2013."},{"key":"3242_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/cid\/cir991","volume":"54","author":"RA Tohme","year":"2012","unstructured":"Tohme RA, Holmberg SD. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin Infect Dis. 2012;54:1167\u201378.","journal-title":"Clin Infect Dis"},{"key":"3242_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ajic.2006.08.002","volume":"35","author":"ME Hellard","year":"2007","unstructured":"Hellard ME, Aitken CK, Hocking JS. Tattooing in prisons\u2014not such a pretty picture. Am J Infect Control. 2007;35:477\u201380.","journal-title":"Am J Infect Control"},{"key":"3242_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1186\/1471-2458-13-981","volume":"13","author":"M Brandolini","year":"2013","unstructured":"Brandolini M, Novati S, De Silvestri A, Tinelli C, Patruno SF, Ranieri R, et al. Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting. BMC Public Health. 2013;13:981.","journal-title":"BMC Public Health"},{"key":"3242_CR12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/IPC.0b013e318142ce16","volume":"15","author":"M Pourahmad","year":"2007","unstructured":"Pourahmad M, Javady AA, Karimi I, Ataei B, Kassaian N. Seroprevalence of and risk factors associated with hepatitis B, hepatitis C, and human immunodeficiency virus among prisoners in Iran. Infect Dis Clin Pract. 2007;15:368\u201372.","journal-title":"Infect Dis Clin Pract"},{"key":"3242_CR13","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1053\/jhep.2001.29303","volume":"34","author":"ME Briggs","year":"2001","unstructured":"Briggs ME, Baker C, Hall R, Gaziano JM, Gagnon D, Bzowej N, et al. Prevalence and risk factors for hepatitis C virus infection at an urban veterans\u2019 administration medical center. Hepatology. 2001;34:1200\u20135.","journal-title":"Hepatology"},{"issue":"Suppl1","key":"3242_CR14","first-page":"S113","volume":"3","author":"Z Nokhodian","year":"2012","unstructured":"Nokhodian Z, Ataei B, Kassaian N, Yaran M, Hassannejad R, Adibi P. Seroprevalence and risk factors of hepatitis C virus among juveniles in correctional center in Isfahan, Iran. J Prev Med. 2012;3(Suppl1):S113\u20137.","journal-title":"J Prev Med"},{"key":"3242_CR15","volume-title":"Differential substance misuse treatment needs of women, ethnic minorities and young offenders in prison: prevalence of substance misuse and treatment needs","author":"J Borrill","year":"2003","unstructured":"Borrill, J., Maden, A., Martin, A., Weaver, T., Stimson, G., Farrell, M. and Barnes, T. Differential substance misuse treatment needs of women, ethnic minorities and young offenders in prison: prevalence of substance misuse and treatment needs (2003). (Available online)."},{"key":"3242_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1360-0443.2006.01316.x","volume":"101","author":"S Fazel","year":"2006","unstructured":"Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction. 2006;101:181\u201391.","journal-title":"Addiction"},{"key":"3242_CR17","volume-title":"Drug dependence treatment: interventions for drug users in prison, United Nations Office on drugs and Crime, Vienna","author":"UNODC","year":"2008","unstructured":"UNODC (2008), Drug dependence treatment: interventions for drug users in prison, United Nations Office on drugs and Crime, Vienna (available online)."},{"key":"3242_CR18","doi-asserted-by":"publisher","unstructured":"Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, et al. Direct-acting antivirals for chronic hepatitis C. Cochrane Database Syst Rev. 2017;6:CD012143. \n                    https:\/\/doi.org\/10.1002\/14651858.CD012143.pub2\n                    \n                  .","DOI":"10.1002\/14651858.CD012143.pub2"},{"key":"3242_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/liv.13212","volume":"37","author":"JJ Feld","year":"2017","unstructured":"Feld JJ, Jacobson IM, Sulkowski MS, Poordad F, Tatsch F, Pawlotsky JM. Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection. Liver Int. 2017;37:5\u201318.","journal-title":"Liver Int"},{"key":"3242_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.7326\/0003-4819-138-3-200302040-00010","volume":"138","author":"SA Allen","year":"2003","unstructured":"Allen SA, Spaulding AC, Osei AM, et al. Treatment of chronic hepatitis C in a state correctional facility. Ann Intern Med. 2003;138:187\u201390.","journal-title":"Ann Intern Med"},{"key":"3242_CR21","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2105\/AJPH.2004.056150","volume":"95","author":"J Farley","year":"2005","unstructured":"Farley J, Vasdev S, Fischer B, et al. Feasibility and outcome of HCV treatment in a Canadian federal prison population. Am J Public Health. 2005;95:1737\u20139.","journal-title":"Am J Public Health"},{"key":"3242_CR22","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1572-0241.2004.30310.x","volume":"99","author":"RK Sterling","year":"2004","unstructured":"Sterling RK, Hofmann CM, Luketic VA, et al. Treatment of chronic hepatitis C virus in the Virginia Department of Corrections: can compliance overcome racial differences to response? Am J Gastroenterol. 2004;99:866\u201372.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 6","key":"3242_CR23","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1186\/1471-2334-14-S6-S17","volume":"14","author":"A Arain","year":"2014","unstructured":"Arain A, Robaeys G, St\u00f6ver H. Hepatitis C in European prisons: a call for an evidence-informed response. BMC Infect Dis. 2014;14(Suppl 6):S17. \n                    https:\/\/doi.org\/10.1186\/1471-2334-14-S6-S17\n                    \n                  .","journal-title":"BMC Infect Dis"},{"issue":"12","key":"3242_CR24","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1001\/jama.2012.374","volume":"307","author":"AC Spaulding","year":"2012","unstructured":"Spaulding AC, Thomas DL. Screening for HCV infection in jails. JAMA. 2012;307(12):1259\u201360. \n                    https:\/\/doi.org\/10.1001\/jama.2012.374.","journal-title":"JAMA"},{"key":"3242_CR25","unstructured":"Council of Europe Annual Penal Statistics. Available from: \n                    http:\/\/wp.unil.ch\/space\/space-i\/prison-stock-on-1st-january\/prison-stock-on-01-jan-2015-2016\/\n                    \n                  . Accessed: 10 Nov 2017."},{"issue":"1","key":"3242_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/09540121.2014.940271","volume":"27","author":"A Uusk\u00fcla","year":"2015","unstructured":"Uusk\u00fcla A, Des Jarlais DC, Raag M, Pinkerton SD, Feelemyer J. Combination prevention for persons who inject drugs in the HIV epidemic in a transitional country: the case of Tallinn, Estonia. AIDS Care. 2015;27(1):105\u201311. \n                    https:\/\/doi.org\/10.1080\/09540121.2014.940271.","journal-title":"AIDS Care"},{"key":"3242_CR27","volume-title":"Preventing fatal overdoses: a systematic review of the effectiveness of take-home naloxone, EMCDDA Papers","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2015","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Preventing fatal overdoses: a systematic review of the effectiveness of take-home naloxone, EMCDDA Papers. Luxembourg: Publications Office of the European Union; 2015."},{"issue":"47","key":"3242_CR28","doi-asserted-by":"publisher","first-page":"20970","DOI":"10.2807\/1560-7917.ES2014.19.47.20970","volume":"19","author":"K Kivimets","year":"2014","unstructured":"Kivimets K, Uusk\u00fcla A. HIV testing and counselling in Estonian prisons, 2012 to 2013: aims, processes and impacts. Euro Surveill. 2014;19(47):20970.","journal-title":"Euro Surveill"},{"key":"3242_CR29","unstructured":"Foreign support. Projects funded from European economic area and Norway grants. Tallinn: Estonian Ministry of Justice. Available from: \n                    http:\/\/www.just.ee\/en\/foreign-support\n                    \n                  . Accessed: 10 Nov 2015."},{"key":"3242_CR30","unstructured":"Vanglateenistus. [Prison Service]. Uimastiseire. [Drug Monitoring Report 2014]. Tallinn: Estonian Ministry of Justice; 2014."},{"key":"3242_CR31","unstructured":"Social Rehabilitation Programmes for Offenders. Prison Service. Prisons Department of Ministry of Justice. Tallinn: Estonian Ministry of Justice. \n                    http:\/\/www.vangla.ee\/en\/socialwork\/social-rehabilitation-programmes-offenders\n                    \n                  . Accessed 24 Jan 2015."},{"key":"3242_CR32","unstructured":"Kroonilise C- hepatiidi ravijuhend. (National Guidelines on treatment of HCV). Tallinn: Estonian Society of Gastroenterology and the Estonian Society for Infectious Diseases in 2006 and updated in 2007 and 2010. \n                    http:\/\/www.esid.ee\/cms\/tl_files\/failid\/failid\/Kroonilise%20C-hepatiidi%20%20ravijuhend%202010.pdf\n                    \n                  ."},{"key":"3242_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289\u201393.","journal-title":"Hepatology"},{"key":"3242_CR34","doi-asserted-by":"publisher","unstructured":"Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Suligoi B, et al. Correlates of HIV, HBV and HCV infections in a prison inmate population: results from a multicenter study Italy. J Med Virol. 2005;76(3):311\u20137. \n                    https:\/\/doi.org\/10.1002\/jmv.20375\n                    \n                  .","DOI":"10.1002\/jmv.20375"},{"key":"3242_CR35","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/add.12107","volume":"108","author":"A Taylor","year":"2013","unstructured":"Taylor A, Munro A, Allen E, Dunleavy K, Cameron S, Miller L, Hickman M. Low incidence of hepatitis C virus among prisoners in Scotland. Addiction. 2013;108:1296\u2013304.","journal-title":"Addiction"},{"key":"3242_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1017\/S0950268803001882","volume":"132","author":"ME Hellard","year":"2004","unstructured":"Hellard ME, Hocking JS, Crofts N. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect. 2004;132:409\u201315.","journal-title":"Epidemiol Infect"},{"key":"3242_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1753-6405.2007.00009.x","volume":"31","author":"T Butler","year":"2007","unstructured":"Butler T, Boonwat L, Hailstone S, Falconer T, Lems P, Ginley T, et al. The 2004 Australian prison entrants\u2019 blood-borne virus and risk behaviour survey. Aust N Z J Public Health. 2007;31:44\u201350.","journal-title":"Aust N Z J Public Health"},{"key":"3242_CR38","first-page":"121","volume":"3","author":"AR Weild","year":"2000","unstructured":"Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health. 2000;3:121\u20136.","journal-title":"Commun Dis Public Health"},{"issue":"10050","key":"3242_CR39","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/S0140-6736(16)30856-X","volume":"388","author":"FL Altice","year":"2016","unstructured":"Altice FL, Azbel L, Stone J, et al. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Lancet (London, England). 2016;388(10050):1228\u201348. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)30856-X\n                    \n                  .","journal-title":"Lancet (London, England)"},{"key":"3242_CR40","doi-asserted-by":"publisher","unstructured":"Jafari S, Copes R, Baharlou S, Etminan M, Buxton J. Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. Int J Infect Dis 2010;14(11):e928\u201340. \n                    https:\/\/doi.org\/10.1016\/j.ijid.2010.03.019\n                    \n                  .","DOI":"10.1016\/j.ijid.2010.03.019"},{"issue":"2","key":"3242_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijid.2008.06.011","volume":"13","author":"ER Miller","year":"2009","unstructured":"Miller ER, Bi P, Ryan P. Hepatitis C virus infection in south Australian prisoners: seroprevalence, seroconversion, and risk factors. Int J Infect Dis. 2009;13(2):201\u20138. \n                    https:\/\/doi.org\/10.1016\/j.ijid.2008.06.011\n                    \n                  .","journal-title":"Int J Infect Dis"},{"issue":"1","key":"3242_CR42","doi-asserted-by":"publisher","first-page":"e0169195","DOI":"10.1371\/journal.pone.0169195","volume":"12","author":"P MAM","year":"2017","unstructured":"MAM P, Bandeira LM, Pompilio MA, Croda J, GRd R, LFP D, et al. Prevalence and Incidence of HCV Infection among Prisoners in Central Brazil. PLoS ONE. 2017;12(1):e0169195.","journal-title":"PLoS ONE"},{"issue":"1","key":"3242_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.27259","volume":"61","author":"JP Messina","year":"2015","unstructured":"Messina JP, Humphreys I, Flaxman A, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61(1):77\u201387. \n                    https:\/\/doi.org\/10.1002\/hep.27259\n                    \n                  .","journal-title":"Hepatology"},{"key":"3242_CR44","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1017\/S0950268806006820","volume":"135","author":"MF Meyer","year":"2007","unstructured":"Meyer MF, Wedemeyer H, Monazahian M, Dreesman J, Manns MP, Lehmann M. Prevalence of hepatitis C in a German prison for young men in relation to country of birth. Epidemiol Infect. 2007;135:274\u201380.","journal-title":"Epidemiol Infect"},{"key":"3242_CR45","doi-asserted-by":"publisher","first-page":"e14559","DOI":"10.5812\/hepatmon.14559","volume":"14","author":"M Tyczyno","year":"2014","unstructured":"Tyczyno M, Halota W, Nowak W, Pawlowska M. Distribution of HCV genotypes in the populations of inmates in polish prison potulice and patients hospitalized in Bydgoszcz. Hepat Mon. 2014;14:e14559.","journal-title":"Hepat Mon"},{"key":"3242_CR46","first-page":"175","volume":"44","author":"T Tallo","year":"2000","unstructured":"Tallo T, Lappalainen M, Tefanova V, Priimagi I. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C in northern Estonia. Acta Virol. 2000;44:175\u20138.","journal-title":"Acta Virol"},{"issue":"2","key":"3242_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.21101\/cejph.a3706","volume":"20","author":"V Brjalin","year":"2012","unstructured":"Brjalin V, Salupere R, Tallo T, Kuznetsova T, Priim\u00e4gi L, Tefanova V. Efficacy of peginterferon alpha-2A and ribavirin combination therapy in treatment-naive Estonian patients with chronic hepatitis C. Cent Eur J Public Health. 2012;20(2):150\u20135.","journal-title":"Cent Eur J Public Health"},{"issue":"Suppl. 5","key":"3242_CR48","first-page":"S158e64","volume":"46","author":"F Negro","year":"2014","unstructured":"Negro F. Epidemiology of hepatitis C in Europe. Dig Liver Dis. 2014;46(Suppl. 5):S158e64.","journal-title":"Dig Liver Dis"},{"key":"3242_CR49","doi-asserted-by":"publisher","unstructured":"Stone J, Martin NK, Hickman M, et al. Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland. Addiction (Abingdon, England). 2017;112(7):1302-14. \n                    https:\/\/doi.org\/10.1111\/add.13783\n                    \n                  .","DOI":"10.1111\/add.13783"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3242-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3242-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3242-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T19:03:35Z","timestamp":1563649415000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3242-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,21]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3242"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3242-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2018,7,21]]},"assertion":[{"value":"18 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study procedures were in accordance with local data protection regulations, and the study was approved by the Tartu University Research Ethics Committee. The analysis was based on preexisting records containing pseudo identification codes which allows tracking care provided to this person but not personal identification. Informed consent was deemed unnecessary according to national regulations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"339"}}